Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Vickers

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Oncology (Toronto, Ont.)|February 19, 2011
Characterization of published errors in high-impact oncology journalsA Molckovsky, M M Vickers, P A Tang
Current Oncology (Toronto, Ont.)|January 10, 2013
Report from the 13th annual Western canadian gastrointestinal cancer consensus conference; calgary, alberta; september 8-10, 2011M M Vickers, J Pasieka, E Dixon, et al.
Current Oncology (Toronto, Ont.)|May 3, 2019
Epidermal growth factor receptor inhibitor-induced hypomagnesemia: a survey of practice patterns among Canadian gastrointestinal medical oncologistsT Thangarasa, J Gotfrit, R A Goodwin, et al.
Current Oncology (Toronto, Ont.)|December 23, 2017
Risk and predictors of suicide in colorectal cancer patients: a Surveillance, Epidemiology, and End Results analysisH H Samawi, A A Shaheen, P A Tang, et al.
Current Oncology (Toronto, Ont.)|November 13, 2012
Continuity clinics in oncology training programs in CanadaJ M Croke, M M Vickers, C E, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2011
Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placeboM M Vickers, E D Powell, T R Asmis, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 8, 2016
Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3M M Vickers, C Lee, D Tu, et al.
Current Oncology (Toronto, Ont.)|June 19, 2014
One compared with two cycles of mitomycin C in chemoradiotherapy for anal cancer: analysis of outcomes and toxicityR Yeung, Y McConnell, G Roxin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2015
Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancerD M Jiang, S Raissouni, J Mercer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2012
Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17M M Vickers, C S Karapetis, D Tu, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Oncology (Toronto, Ont.)|February 19, 2011
Characterization of published errors in high-impact oncology journalsA Molckovsky, M M Vickers, P A Tang
Current Oncology (Toronto, Ont.)|January 10, 2013
Report from the 13th annual Western canadian gastrointestinal cancer consensus conference; calgary, alberta; september 8-10, 2011M M Vickers, J Pasieka, E Dixon, et al.
Current Oncology (Toronto, Ont.)|May 3, 2019
Epidermal growth factor receptor inhibitor-induced hypomagnesemia: a survey of practice patterns among Canadian gastrointestinal medical oncologistsT Thangarasa, J Gotfrit, R A Goodwin, et al.
Current Oncology (Toronto, Ont.)|December 23, 2017
Risk and predictors of suicide in colorectal cancer patients: a Surveillance, Epidemiology, and End Results analysisH H Samawi, A A Shaheen, P A Tang, et al.
Current Oncology (Toronto, Ont.)|November 13, 2012
Continuity clinics in oncology training programs in CanadaJ M Croke, M M Vickers, C E, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2011
Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placeboM M Vickers, E D Powell, T R Asmis, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 8, 2016
Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3M M Vickers, C Lee, D Tu, et al.
Current Oncology (Toronto, Ont.)|June 19, 2014
One compared with two cycles of mitomycin C in chemoradiotherapy for anal cancer: analysis of outcomes and toxicityR Yeung, Y McConnell, G Roxin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2015
Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancerD M Jiang, S Raissouni, J Mercer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 13, 2012
Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17M M Vickers, C S Karapetis, D Tu, et al.
Pageof 1